Clinical Trial Update: CharactHer. ICORG 12-09, V3

View source ↗

Summary

The CharactHer ICORG 12-09 trial investigating HER2-positive and stage II-IV breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Breast Cancer to Iv

Snippet

Sponsor: Cancer Trials Ireland | Conditions: HER2-positive Breast Cancer, TNM Stage II-IV Breast Cancer | Status: TERMINATED